Trials / Completed
CompletedNCT05297409
An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure
Hyperkalemia Registry An Observational Prospective Cohort Study for Long-term Management of Hyperkalemia in Patients With Chronic Kidney Disease or Heart Failure
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 352 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This prospective observational research will be conducted to assess the burden of hyperkalemia including treatment and disease burden of patients in a long-term continuous care from various aspects including adherence to the medication for hyperkalemia and HR-QoLs.
Conditions
Timeline
- Start date
- 2022-05-21
- Primary completion
- 2024-08-28
- Completion
- 2024-08-28
- First posted
- 2022-03-28
- Last updated
- 2025-08-08
Locations
32 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT05297409. Inclusion in this directory is not an endorsement.